ChemBriefRuanyun Edai Technology Inc. Grants Exclusive Cogni AI License to Bionexus Gene Lab Corp. for Malaysian Healthcare
Ruanyun Edai Technology Inc. granted BioNexus Gene Lab Corp. an exclusive license for its Cogni AI healthcare platform in Malaysia, involving a reciprocal share exchange and 10% royalty on technology
www.marketscreener.com · 2026-10-05 23:01